Loading data
OGENYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.19 bn USD | 2.92 bn USD | 2.61 bn USD | 3.3 bn USD | 3.59 bn USD |
| Cost of revenue | 1.26 bn USD | 1.08 bn USD | 911.7 m USD | 1.66 bn USD | 2.13 bn USD |
| Selling, general and administrative expense | — | — | 148.3 m USD | 135.5 m USD | 139.3 m USD |
| Operating profit | 799.4 m USD | 745.3 m USD | 650.2 m USD | 649.5 m USD | 544.2 m USD |
| Interest expense | 270.3 m USD | 254.5 m USD | 221.4 m USD | 166.3 m USD | 158.3 m USD |
| Profit before tax | 560.5 m USD | 520.6 m USD | 473 m USD | 789.3 m USD | 878.5 m USD |
| Income tax expense | 89.8 m USD | 79.1 m USD | 56.2 m USD | 123.6 m USD | 141.2 m USD |
| Net income (reported basis) | 470.7 m USD | 441.5 m USD | 416.8 m USD | 665.7 m USD | 737.3 m USD |
| Basic earnings per share | 2.33 USD/share | 2.2 USD/share | 2.08 USD/share | 3.33 USD/share | 3.68 USD/share |
| Diluted earnings per share | 2.32 USD/share | 2.19 USD/share | 2.07 USD/share | 3.32 USD/share | 3.68 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.